DaVita (DVA) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

DVA Stock Forecast


DaVita stock forecast is as follows: an average price target of $125.50 (represents a -23.54% downside from DVA’s last price of $164.14) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.

DVA Price Target


The average price target for DaVita (DVA) is $125.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $150.00 to $90.00. This represents a potential -23.54% downside from DVA's last price of $164.14.

DVA Analyst Ratings


Hold

According to 3 Wall Street analysts, DaVita's rating consensus is 'Hold'. The analyst rating breakdown for DVA stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 2 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

DaVita Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 07, 2024Kevin FischbeckBank of America Securities$145.00$133.538.59%-11.66%
May 06, 2024Andrew MokBarclays$150.00$134.4511.57%-8.61%
Oct 31, 2022Sarah JamesBarclays$81.00$70.5414.83%-50.65%
Aug 19, 2022Andrew MokUBS$117.00$93.1025.67%-28.72%
Jun 28, 2022David MacDonaldTruist Financial$90.00$79.4413.29%-45.17%
Row per page
Go to

The latest DaVita stock forecast, released on Aug 07, 2024 by Kevin Fischbeck from Bank of America Securities, set a price target of $145.00, which represents a 8.59% increase from the stock price at the time of the forecast ($133.53), and a -11.66% decrease from DVA last price ($164.14).

DaVita Price Target by Period


1M3M12M
# Anlaysts--2
Avg Price Target--$147.50
Last Closing Price$164.14$164.14$164.14
Upside/Downside-100.00%-100.00%-10.14%

In the current month, the average price target of DaVita stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to DaVita's last price of $164.14. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
May 06, 2024BarclaysEqual-WeightEqual-WeightHold
Jan 05, 2023CFRA-HoldUpgrade
Aug 19, 2022UBS-BuyUpgrade
Jun 28, 2022BarclaysEqual-WeightEqual-WeightHold
Row per page
Go to

DaVita's last stock rating was published by Barclays on May 06, 2024. The company gave DVA a "Equal-Weight" rating, the same as its previous rate.

DaVita Financial Forecast


DaVita Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$3.12B$3.00B$2.87B$2.92B$2.95B$2.93B$2.82B$2.94B$2.94B$2.92B$2.82B$2.91B$2.92B$2.88B$2.84B$2.90B$2.90B
Avg Forecast$3.39B$3.48B$3.39B$3.30B$3.38B$3.37B$3.29B$3.20B$3.27B$3.25B$3.15B$3.03B$3.01B$3.02B$2.95B$2.84B$2.93B$2.98B$2.93B$2.89B$2.91B$2.91B$2.87B$2.84B$2.93B$2.94B$2.93B$2.84B$2.92B$2.85B
High Forecast$3.42B$3.51B$3.42B$3.33B$3.41B$3.40B$3.32B$3.22B$3.29B$3.25B$3.15B$3.03B$3.04B$3.04B$2.98B$2.86B$2.96B$2.98B$2.93B$2.89B$2.91B$2.91B$2.87B$2.84B$2.93B$2.94B$2.93B$2.84B$2.92B$2.85B
Low Forecast$3.37B$3.45B$3.37B$3.28B$3.35B$3.34B$3.27B$3.18B$3.26B$3.25B$3.15B$3.03B$2.99B$3.00B$2.93B$2.82B$2.91B$2.98B$2.93B$2.89B$2.91B$2.91B$2.87B$2.84B$2.93B$2.94B$2.93B$2.84B$2.92B$2.85B
# Analysts111111123122454433334444445443
Surprise %-------------1.03%1.02%1.01%1.00%0.99%1.00%0.98%1.01%1.01%1.02%0.99%0.99%1.00%0.98%1.00%0.99%1.02%

DaVita's average Quarter revenue forecast for Dec 23 based on 4 analysts is $3.01B, with a low forecast of $2.99B, and a high forecast of $3.04B. DVA's average Quarter revenue forecast represents a -3.62% decrease compared to the company's last Quarter revenue of $3.12B (Sep 23).

DaVita EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111123122454433334444445443
EBITDA-------------$664.71M$590.34M$493.47M$442.52M$501.30M$602.61M$509.47M$561.79M$637.75M$675.35M$609.47M$549.33M$599.96M$593.09M$612.76M$632.54M$623.39M
Avg Forecast$670.95M$688.26M$671.43M$653.52M$667.89M$665.89M$651.05M$633.30M$646.05M$642.28M$623.40M$642.08M$594.98M$597.12M$583.82M$583.71M$482.61M$595.52M$587.06M$530.64M$582.95M$582.57M$573.98M$472.95M$585.55M$587.57M$585.36M$433.76M$584.42M$570.10M
High Forecast$676.86M$694.33M$677.34M$659.27M$673.77M$671.75M$656.79M$637.27M$650.03M$642.52M$623.40M$770.49M$600.93M$601.65M$588.96M$700.45M$579.14M$595.52M$587.06M$636.77M$582.95M$582.57M$573.98M$567.53M$585.55M$587.57M$585.36M$520.51M$584.42M$570.10M
Low Forecast$665.76M$682.95M$666.24M$648.47M$662.73M$660.74M$646.02M$629.33M$644.06M$642.05M$623.40M$513.66M$591.01M$593.75M$579.31M$466.97M$386.09M$595.52M$587.06M$424.51M$582.95M$582.57M$573.98M$378.36M$585.55M$587.57M$585.36M$347.01M$584.42M$570.10M
Surprise %-------------1.11%1.01%0.85%0.92%0.84%1.03%0.96%0.96%1.09%1.18%1.29%0.94%1.02%1.01%1.41%1.08%1.09%

4 analysts predict DVA's average Quarter EBITDA for Dec 23 to be $594.98M, with a high of $600.93M and a low of $591.01M. This is -10.49% lower than DaVita's previous annual EBITDA (Sep 23) of $664.71M.

DaVita Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111123122454433334444445443
Net Income-------------$246.63M$178.69M$170.67M$113.16M$164.69M$224.81M$162.12M$249.43M$259.75M$293.82M$237.40M$254.00M$217.54M$201.60M$239.59M$244.87M$143.27M
Avg Forecast$281.51M$365.13M$327.69M$258.79M$218.19M$284.98M$253.09M$207.01M$183.93M$233.68M$222.34M$223.44M$139.83M$172.56M$146.46M$203.13M$181.02M$157.10M$185.80M$184.66M$160.04M$200.58M$193.40M$202.18M$166.00M$128.04M$117.74M$180.92M$147.99M$110.47M
High Forecast$284.74M$369.31M$331.45M$261.75M$220.69M$288.24M$255.99M$209.38M$192.26M$234.61M$222.36M$268.13M$152.63M$188.79M$148.14M$243.76M$217.22M$157.10M$185.80M$221.60M$164.15M$200.58M$193.40M$242.62M$166.00M$128.04M$117.74M$217.10M$147.99M$110.47M
Low Forecast$278.69M$361.47M$324.40M$256.19M$216.00M$282.12M$250.55M$204.93M$175.61M$232.75M$222.32M$178.75M$123.38M$158.04M$144.99M$162.50M$144.81M$157.10M$185.80M$147.73M$155.93M$200.58M$193.40M$161.75M$166.00M$128.04M$117.74M$144.73M$147.99M$110.47M
Surprise %-------------1.43%1.22%0.84%0.63%1.05%1.21%0.88%1.56%1.29%1.52%1.17%1.53%1.70%1.71%1.32%1.65%1.30%

DaVita's average Quarter net income forecast for Dec 23 is $139.83M, with a range of $123.38M to $152.63M. DVA's average Quarter net income forecast represents a -43.30% decrease compared to the company's last Quarter net income of $246.63M (Sep 23).

DaVita SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111123122454433334444445443
SG&A-------------$376.88M$364.02M$331.61M$379.71M$365.45M$315.22M$294.82M$322.72M$293.10M$298.09M$281.43M$304.52M$363.28M$316.21M$263.58M$278.43M$298.74M
Avg Forecast$370.38M$379.94M$370.64M$360.76M$368.69M$367.58M$359.40M$349.60M$356.64M$354.55M$344.13M$406.33M$328.44M$329.62M$322.28M$369.39M$311.61M$325.04M$320.42M$335.81M$318.18M$317.97M$313.28M$239.68M$319.60M$320.70M$319.49M$199.03M$318.98M$311.16M
High Forecast$373.64M$383.29M$373.91M$363.94M$371.94M$370.82M$362.56M$351.79M$358.83M$354.68M$344.13M$487.60M$331.73M$332.13M$325.12M$443.27M$373.93M$325.04M$320.42M$402.97M$318.18M$317.97M$313.28M$287.61M$319.60M$320.70M$319.49M$238.83M$318.98M$311.16M
Low Forecast$367.52M$377.00M$367.78M$357.97M$365.84M$364.75M$356.62M$347.41M$355.54M$354.43M$344.13M$325.07M$326.25M$327.76M$319.79M$295.51M$249.29M$325.04M$320.42M$268.65M$318.18M$317.97M$313.28M$191.74M$319.60M$320.70M$319.49M$159.22M$318.98M$311.16M
Surprise %-------------1.14%1.13%0.90%1.22%1.12%0.98%0.88%1.01%0.92%0.95%1.17%0.95%1.13%0.99%1.32%0.87%0.96%

DaVita's average Quarter SG&A projection for Dec 23 is $328.44M, based on 4 Wall Street analysts, with a range of $326.25M to $331.73M. The forecast indicates a -12.85% fall compared to DVA last annual SG&A of $376.88M (Sep 23).

DaVita EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111123122454433334444445443
EPS-------------$2.70$1.96$1.89$1.26$1.81$2.38$1.68$2.47$2.48$2.76$2.18$2.27$1.80$1.65$1.92$1.89$1.38
Avg Forecast$3.28$4.26$3.82$3.02$2.54$3.32$2.95$2.41$2.14$2.72$2.59$1.95$1.63$2.01$1.71$1.18$0.93$1.77$2.09$1.87$1.80$2.25$2.17$1.79$1.87$1.44$1.32$1.48$1.66$1.24
High Forecast$3.32$4.30$3.86$3.05$2.57$3.36$2.98$2.44$2.24$2.73$2.59$1.95$1.78$2.20$1.73$1.19$0.94$1.77$2.09$1.87$1.85$2.25$2.17$1.79$1.87$1.44$1.32$1.48$1.66$1.24
Low Forecast$3.25$4.21$3.78$2.99$2.52$3.29$2.92$2.39$2.05$2.71$2.59$1.95$1.44$1.84$1.69$1.17$0.92$1.77$2.09$1.87$1.75$2.25$2.17$1.79$1.87$1.44$1.32$1.48$1.66$1.24
Surprise %-------------1.34%1.15%1.61%1.35%1.02%1.14%0.90%1.37%1.10%1.27%1.22%1.22%1.25%1.25%1.30%1.14%1.11%

According to 4 Wall Street analysts, DaVita's projected average Quarter EPS for Dec 23 is $1.63, with a low estimate of $1.44 and a high estimate of $1.78. This represents a -39.63% decrease compared to DVA previous annual EPS of $2.70 (Sep 23).

DaVita Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
AMNAMN Healthcare Services$25.70$89.80249.42%Buy
CYHCommunity Health Systems$3.75$11.00193.33%Buy
ACHCAcadia Healthcare Company$38.59$82.33113.35%Buy
SGRYSurgery Partners$23.35$40.8074.73%Buy
AMEDAmedisys$90.16$143.3859.03%Hold
OPCHOption Care Health$22.49$29.5031.17%Buy
UHSUniversal Health Services$197.61$208.475.50%Hold
ENSGEnsign Group$147.35$148.200.58%Buy
EHCEncompass Health$99.40$97.00-2.41%Buy
HCAHCA Healthcare$332.24$310.75-6.47%Buy
THCTenet Healthcare$147.92$128.60-13.06%Buy
DVADaVita$164.14$125.50-23.54%Hold

DVA Forecast FAQ


Is DaVita a good buy?

No, according to 3 Wall Street analysts, DaVita (DVA) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 33.33% of DVA's total ratings.

What is DVA's price target?

DaVita (DVA) average price target is $125.5 with a range of $90 to $150, implying a -23.54% from its last price of $164.14. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will DaVita stock go up soon?

According to Wall Street analysts' prediction for DVA stock, the company can go down by -23.54% (from the last price of $164.14 to the average price target of $125.5), down by -8.61% based on the highest stock price target, and down by -45.17% based on the lowest stock price target.

Can DaVita stock reach $200?

DVA's average twelve months analyst stock price target of $125.5 does not support the claim that DaVita can reach $200 in the near future.

What are DaVita's analysts' financial forecasts?

DaVita's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $13.24B (high $13.35B, low $13.14B), average EBITDA is $2.62B (high $2.64B, low $2.6B), average net income is $963.27M (high $974.31M, low $953.6M), average SG&A $1.45B (high $1.46B, low $1.43B), and average EPS is $11.23 (high $11.36, low $11.11). DVA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $13.57B (high $13.69B, low $13.47B), average EBITDA is $2.68B (high $2.71B, low $2.66B), average net income is $1.23B (high $1.25B, low $1.22B), average SG&A $1.48B (high $1.49B, low $1.47B), and average EPS is $14.37 (high $14.54, low $14.23).

Did the DVA's actual financial results beat the analysts' financial forecasts?

Based on DaVita's last annual report (Dec 2022), the company's revenue was $11.61B, which missed the average analysts forecast of $11.73B by -1.03%. Apple's EBITDA was $2.06B, missing the average prediction of $2.2B by -6.37%. The company's net income was $768.19M, beating the average estimation of $708.58M by 8.41%. Apple's SG&A was $1.36B, beating the average forecast of $1.29B by 4.82%. Lastly, the company's EPS was $8.26, beating the average prediction of $6.66 by 24.11%. In terms of the last quarterly report (Sep 2023), DaVita's revenue was $3.12B, beating the average analysts' forecast of $3.02B by 3.39%. The company's EBITDA was $664.71M, beating the average prediction of $597.12M by 11.32%. DaVita's net income was $246.63M, beating the average estimation of $172.56M by 42.93%. The company's SG&A was $376.88M, beating the average forecast of $329.62M by 14.34%. Lastly, the company's EPS was $2.7, beating the average prediction of $2.01 by 34.24%